Acne and similar skin conditions are a pandemic problem that effects 100's of millions world wide. For more severe cases the best treatments come with many potentially dangerous side effects. This causes people all over the world to suffer from the stigma of Acne and associated skin conditions.
Biomimetics has found a better solution. Utilizing their process they have discovered a terpenoid molecule capable of not only working as effective as current leading brands but potentially curing the underlying causes of Acne. Being topically applied and activated leads to potentially much safer applications for the treatment of skin conditions.
New series of compounds based on a near extinc plant. Extracts retain activity in male rats, increasing overall mating events to a similar level as Sildenafil (Viagra). This compound without any notable alkaloids or sterols was ignored by the scientific community for a lack of understanding allowing the opportunity for a first mover advantage on a potentially new type of drug.
Inflammatory illnesses and issues are on the rise, from Arthritis (known to affect 1/3 of adults) to medications, surgery, dental, and acne; the uses of anti-inflammatory are more than commonplace, they are expected.
Unfortunately, traditional Anti-inflammatory agents are either moderately effective or have serious negative effects such as causing damage to the liver, kidneys, and stomach lining.
With at least 1/3 of the population taking some form of anti-inflammatory, we are seriously hurting our population and shortening lifespans.
We have found a non-psychotropic compound found within plants such as cannabis. Current clinical studies show that it is not only more effective than leading anti-inflammatories but carries fewer side effects and dangers.
Unfortunately, it is found in such minute quantities in nature that it makes it not only expensive and nearly impossible to supply for clinical trials, but commercially impossible as a cost-effective pharmaceutical.
These problems, however, become non-existent when utilizing Biomimetic’s process, allowing for its creation at a fraction of the cost of current methods at volumes previously inaccessible to the market.